血流限制作为一种潜在的治疗方法,以恢复COVID-19感染后的身体功能
Isaac J Wedig1,2, John J Durocher3, John McDaniel4
1Department of Kinesiology and Integrative Physiology, Michigan Technological University, Houghton, MI, United States.
Frontiers in physiology
|August 7, 2023
概括
血流限制 (BFR) 可能有助于COVID-19幸存者恢复肌肉质量和力量. 这种疗法可以减轻急性疾病期间的肌肉损失,并在康复期间帮助恢复.
科学领域:
- 生理学 生理学 生理学
- 康复医学 康复医学 康复医学
- 病理学 病理学 病理学
背景情况:
- COVID-19幸存者经常经历持续的肌肉质量和力量缺陷,影响身体功能.
- 恢复身体能力对于减轻长期COVID-19后果至关重要.
- 血流限制 (BFR) 是各种疾病阶段的潜在治疗干预措施.
研究的目的:
- 提出血液流量限制 (BFR) 作为COVID-19恢复的治疗策略.
- 假设BFR在缓解急性感染期间肌肉损失中的作用.
- 探索BFR作为高强度运动的替代品,用于COVID-19后康复.
主要方法:
- 在COVID-19疾病阶段实施BFR的理论框架开发.
- 关于BFR对肌肉和有氧能力的生理影响的文献综述.
- 假设急性感染的被动BFR和康复的基于炼的BFR.
主要成果:
- 被动BFR可能会在急性COVID-19期间预防肌肉缩.
- 使用BFR的运动可能是高强度训练的有效替代品,用于肌肉和有氧恢复.
- BFR可能会解决COVID-19的潜在病理生理学,使多个器官系统受益.
结论:
- BFR为COVID-19患者提供了一个有希望的,适应性的治疗方法.
- 在整个疾病和康复过程中实施BFR可以改善患者的治疗结果.
- 需要进一步研究和对COVID-19和严重疾病的BFR进行临床考虑.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
263
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
263
01:29Blood Flow
70.2K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
70.2K
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16